Population health & analytics · Population health services
Syra Health
Syra Health is a public healthcare company with a population-health analytics and services segment serving government and community health programs. It is not an EHR or hospital capacity-optimization tool.
Strong fit
- State and community programs that need population health analytics and related services from a company with public financial reports
- Buyers who will track program results and whether the contract is delivered after go-live
- Teams comparing smaller public population health companies rather than large ACO suites
Weak fit
- Buyers of hospital operating room capacity tools, which is LeanTaaS's focus
- Community health centers that only need a small analytics dashboard with no services
- Groups shopping for an EHR
Bottom line
Syra Health is worth considering for government and community health programs that want a smaller population health analytics and services vendor with public financial reporting. It suits buyers who will track whether its programs move contract measures. Buyers wanting enterprise value-based care suites may prefer Lightbeam or Persivia.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Syra Health is a public healthcare company. Its population health unit provides analytics and related services for government and community health programs.
Because it is public, its financial reports are open, unlike most private ACO platforms, and that unit has grown sharply.
Gregory Alexander became CEO in early 2026 after earlier leadership changes, which buyers should ask about as usual.
Results depend on whether program work and analytics move contract measures.
It is narrower than the large value-based care suites from Lightbeam or Persivia, and different from Azara's quality tools for community health centers.
Setup mixes software and services, and pricing is custom.
Among the population health tools we review, Syra scores just below Azara for openness at a moderate size.
Azara suits community health center quality work, and Olio suits post-acute care coordination. Persivia or Lightbeam suit broader value-based care platforms for large buyers.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Azara Healthcare | 7.6 | 7.2 |
| Cozeva | 7.5 | 7.2 |
| Persivia | 7.4 | 7.1 |
| Syra Health | 7.4 | 7.1 |
| Certilytics | 7.3 | 7.0 |
| Trella Health | 7.3 | 7.0 |
| IMAT Solutions | 7.0 | 6.7 |
| Elligint Health | 6.9 | 6.6 |
| Olio | 6.9 | 6.7 |
| Lightbeam Health Solutions | 6.8 | 6.5 |
| Relevant Healthcare | 6.8 | 6.6 |
| Hexplora | 6.7 | 6.5 |
Pricing
| Item | Detail |
|---|---|
| Model | Custom population health analytics and services contracts. As a public company, it files financial reports with the SEC. |
| What usually drives cost | Program scope, analytics modules, and consulting services. |
| What to ask before you buy | Contract cost for your population and which deliverables are software and which are services. |
| Published pricing | Syra Health does not publish prices. Its SEC filings report results by business unit. |
Syra Health's SEC filings break out results for its population health unit.
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Syra Health to function | |
| A named population health or quality owner who can direct care gap work | Dashboards with no owner get ignored. |
| A clear definition of which patients count, agreed with finance | A vague patient count wipes out claimed savings. |
| A list of EHR, claims, and admission and discharge alert feeds | Missing data brings back blind spots. |
| Care managers or partners with time to act on lists | Lists nobody works are not results. |
| Contract measures chosen before kickoff | Changing the target midway wastes the work. |
| What will maximize your value | |
| Track closed gaps, readmissions, or use of services every week for 90 days | Counting logins does not show results. |
| Start with one patient group or partner network | A small real win is worth more than a broad launch with nothing behind it. |
| Drop duplicate spreadsheet lists after a month of running both | Entering everything twice doubles the cost. |
| Review high-risk or transferring patients nobody has reached in a regular huddle | Queues nobody watches hide failure. |
| Send a quarterly results summary to clinical leaders | Hidden backlogs surprise the board. |
| Deal-breakers | |
| You have no value-based, quality, or post-acute program to act on. | |
| Nobody will own follow-up work. | |
| You refuse any EHR or claims data sharing. | |
| You expect a population health tool to replace your EHR. | |
| Leaders will not measure results. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Plan and data | 4-8 weeks to define patients, data feeds, and success measures. |
| 2 | Connect | 2-4 months to connect claims, EHR, and admission alerts, then check the data. |
| 3 | Pilot | 1-2 months with one contract, site, or group of partners. |
| 4 | Expand | Ongoing: more patients and fine-tuning of care work. |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.